Regarding the appropriateness of including this class of glycogenosis in newborn screening, interesting work has shown that the value of biotinidase enzyme activity in these patients is high, with a sensitivity of 100% for patients with GSD Ia, GSD I non-a, and GSD VI, 62% for GSD III, and 77% for GSD IX [99]. Here, BTD is linked to disorder of glycogen metabolism.